Back to search

University of Southampton

Using RNA sequencing to investigate therapeutic strategies in paediatric cancer

Abstract

dc:description.abstract

Neuroblastoma and rhabdomyosarcoma are two paediatric cancers characterised by poor prognosis and high relapse rates in high-risk cases. There is a need to understand treatment resistance/relapse and find more effective therapeutic options for these patients. Neuroblastoma arises from neural crest cells of the sympathetic nervous system that show impaired differentiation, this may involve promoting differentiation in minimal residual disease to reduce the risk of relapse. Two single agent treatments have been shown to promote neuroblastoma differentiation; EZH2, a histone methyltransferase that controls essential cellular processes, and retinoic acid, currently used in standard of care treatment for neuroblastoma. Whether the combination of both treatments could enhance differentiation has not yet been explored. This research aimed to investigate mechanisms of actions of the combination of EZH2 inhibitors with retinoic acid through the analysis of bulk RNA sequencing data to determine whether the combination therapy might further promote neuroblastoma differentiation, reduce minimal residual disease and risk of relapse. Rhabdomyosarcoma is the most common soft tissue sarcoma in children. While most tumours initially respond to treatment, relapse and acquired resistance are common, leading to poor survival outcomes. Understanding why this resistance to therapy occurs may help to predict patient response, identify targets in resistant cells and ultimately prevent relapse. This research aimed to identify and validate a molecular signature of therapy resistance for resistant rhabdomyosarcoma. This was attempted through the analysis of RNA sequencing data from models of intrinsic and acquired chemotherapy resistance, as well as using a machine learning approach. Ultimately, these signatures may be applied to patient samples to predict treatment response, to identify tumours at high risk of recurrence, and to select effective treatments for these patients.

Degree

thesis:*
Name dc:type.qualificationname
Ph.D.
Level dc:type.qualificationlevel
doctoral
Grantor dc:publisher.institution
University of Southampton
Year dc:date.issued
2026

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Putnam, Christina Maria
Advisors dc:contributor.advisor
  • Walters, Zoë
  • Tapper, William
ORCID person:identifier.orcid

Rights

Language dc:language
English, eng

Chain of custody

source
Harvested from
University of Southampton
Base URL
eprints.soton.ac.uk/cgi/oai2
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
related terms
citation

Putnam, Christina Maria. Using RNA sequencing to investigate therapeutic strategies in paediatric cancer. doctoral thesis, University of Southampton, 2026.